The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial-Reference-Cited by-同舟云学术

The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial

Published:2021-10-19 Issue: Volume: Page:
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Soldat-Stanković V.,Popović-Pejičić S.,Stanković S.,Prtina A.,Malešević G.,Bjekić-Macut J.,Livadas S.,Ognjanović S.,Mastorakos G.,Micić D.,Macut D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s40618-021-01691-5.pdf

Reference51 articles.

1. Conway G, Dewailly D, Diamanti-Kandarakis E et al (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:P1-29. https://doi.org/10.1530/EJE-14-0253

2. Echiburú B, Pérez-Bravo F, Galgani JE et al (2018) Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids 130:15–21. https://doi.org/10.1016/j.steroids.2017.12.009

3. Barber TM, Franks S (2013) Adipocyte biology in polycystic ovary syndrome. Mol Cell Endocrinol 373:68–76. https://doi.org/10.1016/j.mce.2012.10.010

4. Panidis D, Tziomalos K, Misichronis G et al (2012) Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 27:541–549. https://doi.org/10.1093/humrep/der418

5. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83. https://doi.org/10.1006/bbrc.1999.0255

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of dual therapy of acarbose plus myo-inositol on the thyroid profile in women with polycystic ovary syndrome;Journal of Pharmacy & Pharmacognosy Research;2024-11-01

2. Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome – A randomized controlled trial;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications;Current Psychiatry Reports;2024-08-31

4. Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging;Frontiers in Pharmacology;2024-08-13

5. European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire;European Journal of Endocrinology;2024-08